Brodogradiliste Viktor Lenac d.d. (ZSE:VLEN)
3.960
0.00 (0.00%)
At close: Nov 14, 2025
ZSE:VLEN Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 71.12 | 68.26 | 71.69 | 82.37 | 34.2 | 35.1 | Upgrade |
Other Revenue | 15.29 | 18.45 | 15.07 | 1.09 | 5.26 | 3.93 | Upgrade |
| 86.41 | 86.71 | 86.76 | 83.46 | 39.46 | 39.03 | Upgrade | |
Revenue Growth (YoY) | -8.63% | -0.06% | 3.95% | 111.53% | 1.09% | -8.57% | Upgrade |
Cost of Revenue | 62.17 | 61.68 | 61.67 | 51.14 | 22 | 20.12 | Upgrade |
Gross Profit | 24.24 | 25.03 | 25.09 | 32.32 | 17.45 | 18.91 | Upgrade |
Selling, General & Admin | 9.27 | 8.64 | 7.45 | 8.66 | 7.13 | 7.16 | Upgrade |
Other Operating Expenses | 3.49 | 3.51 | 4.77 | 3.53 | 2.87 | 2.84 | Upgrade |
Operating Expenses | 20.97 | 19 | 18.72 | 24.42 | 14.58 | 14.17 | Upgrade |
Operating Income | 3.27 | 6.03 | 6.37 | 7.89 | 2.87 | 4.74 | Upgrade |
Interest Expense | -0.02 | -0.03 | -0.05 | -0.09 | -0.17 | -0.22 | Upgrade |
Interest & Investment Income | 0.14 | 0.14 | 0.1 | 0.03 | 0.03 | 0.03 | Upgrade |
Currency Exchange Gain (Loss) | -0.62 | 0.46 | -0.41 | 0.45 | 0.34 | 0.07 | Upgrade |
Other Non Operating Income (Expenses) | -0.04 | - | 0.01 | 1.41 | - | 0.02 | Upgrade |
EBT Excluding Unusual Items | 2.73 | 6.6 | 6.03 | 9.69 | 3.07 | 4.62 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.01 | Upgrade |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade |
Asset Writedown | -0 | -0 | -0 | -0.01 | -0.01 | -0.01 | Upgrade |
Legal Settlements | - | - | -0.25 | -1.6 | -0.04 | -0.03 | Upgrade |
Other Unusual Items | 0.03 | 0.03 | - | - | 0 | 0.83 | Upgrade |
Pretax Income | 2.77 | 6.64 | 5.79 | 8.1 | 3.06 | 5.59 | Upgrade |
Income Tax Expense | 0.57 | 1.21 | 1.06 | 2.65 | 0.56 | 0.87 | Upgrade |
Earnings From Continuing Operations | 2.21 | 5.43 | 4.73 | 5.45 | 2.51 | 4.73 | Upgrade |
Minority Interest in Earnings | 0.08 | -0 | -0 | -0.03 | -0 | -0.02 | Upgrade |
Net Income | 2.29 | 5.42 | 4.73 | 5.42 | 2.51 | 4.71 | Upgrade |
Net Income to Common | 2.29 | 5.42 | 4.73 | 5.42 | 2.51 | 4.71 | Upgrade |
Net Income Growth | -56.13% | 14.77% | -12.87% | 116.27% | -46.76% | 67.77% | Upgrade |
Shares Outstanding (Basic) | - | 18 | 14 | 16 | 16 | 16 | Upgrade |
Shares Outstanding (Diluted) | - | 18 | 14 | 16 | 16 | 16 | Upgrade |
Shares Change (YoY) | - | 30.07% | -12.87% | -0.13% | 0.16% | -0.77% | Upgrade |
EPS (Basic) | - | 0.30 | 0.34 | 0.34 | 0.16 | 0.30 | Upgrade |
EPS (Diluted) | - | 0.30 | 0.34 | 0.34 | 0.16 | 0.30 | Upgrade |
EPS Growth | - | -11.77% | - | 116.55% | -46.84% | 69.08% | Upgrade |
Free Cash Flow | 2.6 | -2.17 | -2.66 | 14.38 | 2.29 | 4.68 | Upgrade |
Free Cash Flow Per Share | - | -0.12 | -0.19 | 0.90 | 0.14 | 0.29 | Upgrade |
Dividend Per Share | - | - | - | - | 0.156 | - | Upgrade |
Gross Margin | 28.05% | 28.86% | 28.92% | 38.72% | 44.23% | 48.44% | Upgrade |
Operating Margin | 3.78% | 6.95% | 7.34% | 9.46% | 7.27% | 12.14% | Upgrade |
Profit Margin | 2.65% | 6.25% | 5.45% | 6.50% | 6.36% | 12.07% | Upgrade |
Free Cash Flow Margin | 3.00% | -2.51% | -3.07% | 17.23% | 5.81% | 11.99% | Upgrade |
EBITDA | 11.42 | 12.83 | 12.87 | 19.59 | 7.45 | 8.91 | Upgrade |
EBITDA Margin | 13.22% | 14.79% | 14.83% | 23.47% | 18.89% | 22.83% | Upgrade |
D&A For EBITDA | 8.15 | 6.8 | 6.5 | 11.69 | 4.59 | 4.17 | Upgrade |
EBIT | 3.27 | 6.03 | 6.37 | 7.89 | 2.87 | 4.74 | Upgrade |
EBIT Margin | 3.78% | 6.95% | 7.34% | 9.46% | 7.27% | 12.14% | Upgrade |
Effective Tax Rate | 20.38% | 18.27% | 18.28% | 32.72% | 18.16% | 15.51% | Upgrade |
Revenue as Reported | 89.43 | 89.73 | 87.68 | 85.28 | 39.82 | 40.53 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.